Last Updated: November 13, 2026

Sciegen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS

SCIEGEN PHARMS has one hundred and seventeen approved drugs.

There is one tentative approval on SCIEGEN PHARMS drugs.

Summary for Sciegen Pharms

US Patents:	0
Tradenames:	93
Ingredients:	92
NDAs:	117

Drugs and US Patents for Sciegen Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sciegen Pharms	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	204165-002	Sep 15, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	205794-002	Mar 1, 2016	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	TABLET;ORAL	210935-001	Mar 20, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	LISINOPRIL	lisinopril	TABLET;ORAL	212041-001	Sep 15, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	LACOSAMIDE	lacosamide	TABLET;ORAL	205237-001	Mar 17, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	203855-006	Oct 28, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	205236-004	May 26, 2017	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.